Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferritin heavy chain 1 pseudogene 5 (FTH1P5) is a processed pseudogene belonging to the ferritin gene family, which includes multiple functional genes and numerous related pseudogenes[1][2]. Pseudogenes like FTH1P5 do not code for functional proteins due to mutations or the absence of regulatory elements necessary for transcription/translation. However, recent evidence suggests that some ferritin pseudogenes may modulate gene expression of their parental genes (like FTH1), for example by acting as competing endogenous RNAs (ceRNAs), sequestering microRNAs that also target the canonical FTH1 gene, thereby potentially influencing iron metabolism and cancer biology[2][7]. At present, FTH1P5 itself is not considered a direct therapeutic target such as a receptor or enzyme, but pseudogenes in the ferritin family may play indirect regulatory roles in biological processes, particularly those connected to cancer and iron homeostasis[2][7]. There are no known drugs, direct mechanisms of action, biomarkers, or safety concerns specifically associated with FTH1P5.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferritin heavy chain 1 pseudogene 5 (FTH1P5).